Doxorubicin Hydrochloride Injection, Solution
Product Images NDC 0143-9088

9 FDA label images from Hikma Pharmaceuticals Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Doxorubicin Hydrochloride (NDC 0143-9088). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Doxorubicin Liquid Novaplus 1)

Structure (Doxorubicin   Liquid   Novaplus 1)
Chemical structure diagram of Doxorubicin Hydrochloride (C27H29NO11·HCl) with molecular weight 579.99, showing its molecular configuration and hydroxyl, carbonyl, methoxy, and amino groups.*
FDA Label Image

Fig. 1 (Doxorubicin Liquid Novaplus 2)

Fig. 1 (Doxorubicin   Liquid   Novaplus 2)
A meta-analysis forest plot displaying hazard ratios with 95% confidence intervals for disease-free survival across six clinical trials comparing Doxorubicin-based treatment to CMF. The horizontal axis ranges from 0 to 2, with a marked boundary of non-inferiority at 1.06, showing individual study data points and a combined summary diamond representing overall effect size.*
FDA Label Image

Fig.2 (Doxorubicin Liquid Novaplus 3)

Fig.2 (Doxorubicin   Liquid   Novaplus 3)
A forest plot titled 'Figure 2. Meta-analysis of Overall Survival' showing hazard ratios with 95% confidence intervals from multiple clinical trials comparing Doxorubicin-based treatments versus CMF. The horizontal axis ranges from 0 to 2, indicating 'DOXO BETTER THAN CMF' on the left and 'DOXO WORSE THAN CMF' on the right. Individual trial results are displayed as squares with error bars, and the pooled summary is shown as a diamond.*
FDA Label Image

Vial (Doxorubicin Liquid Novaplus 4)

Vial (Doxorubicin   Liquid   Novaplus 4)
Label for Doxorubicin Hydrochloride Injection, USP 10 mg per 5 mL (2 mg/mL) intravenous solution. The sterile isotonic solution is supplied in a 5 mL single-dose vial by Hikma Pharmaceuticals USA Inc. The label includes usage instructions, storage conditions, preservative status, and a warning about severe cellulitis, vesication, and tissue necrosis risk if extravasated.*
FDA Label Image

Vial (Doxorubicin Liquid Novaplus 5)

Vial (Doxorubicin   Liquid   Novaplus 5)
Label for Doxorubicin Hydrochloride Injection, USP, 20 mg per 10 mL (2 mg/mL) sterile isotonic solution, intravenous use only. The label includes dosage concentration, administration route, storage instructions, warnings, and manufacturer details, distributed by Hikma Pharmaceuticals USA Inc.*
FDA Label Image

Vial (Doxorubicin Liquid Novaplus 6)

Vial (Doxorubicin   Liquid   Novaplus 6)
Label for Doxorubicin Hydrochloride Injection, USP 2 mg/mL in a 25 mL single dose vial by Hikma Pharmaceuticals USA Inc. The label specifies intravenous use only, sterile isotonic solution, and includes dosage and storage instructions, warnings about tissue necrosis, and manufacturer details from THYMOORGAN PHARMAZIE GmbH, Germany.*
FDA Label Image

Vial (Doxorubicin Liquid Novaplus 7)

Vial (Doxorubicin   Liquid   Novaplus 7)
Label for Doxorubicin Hydrochloride Injection, USP, 200 mg per 100 mL (2 mg/mL) sterile isotonic solution in a 100 mL multiple dose vial. Product is for intravenous use only and labeled Rx only. Manufactured by Thymoorgan Pharmazie GmbH, Germany, and distributed by Hikma Pharmaceuticals USA Inc. The label includes storage instructions to keep refrigerated and warnings about severe tissue reactions if extravasated.*
FDA Label Image

Representative Serialization Image (Doxorubicin Liquid Novaplus 8)

Representative Serialization Image (Doxorubicin   Liquid   Novaplus 8)
Label from a vial of Doxorubicin Hydrochloride injection, solution 2 mg/mL, by Hikma Pharmaceuticals USA Inc. The label displays a QR code and includes fields for GTIN, serial number, expiration date, and lot number.*
FDA Label Image

Representative Serialization Image (Doxorubicin Liquid Novaplus 9)

Representative Serialization Image (Doxorubicin   Liquid   Novaplus 9)
Label for Doxorubicin Hydrochloride injection, solution, 2 mg/mL by Hikma Pharmaceuticals USA Inc. shows a 2D barcode and printed text with lot number, expiration date, GTIN, and serial number information, used for product identification and tracking.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.